Verbatim response from Perplexity
Wegovy is prescribed more easily by online clinics for weight loss because it is the only medication FDA-approved specifically for chronic weight management, whereas Ozempic is approved only for type 2 diabetes and its use for weight loss is considered off-label and generally advised against due to supply constraints [1][3][6].
Key Reasons Online Clinics Prefer Wegovy for Weight Loss:
| Factor | Wegovy | Ozempic |
|---|---|---|
| FDA Approval | Approved for chronic weight management in adults with obesity (BMI ≥30) or weight-related conditions (BMI ≥27) [3][6] | Approved only for type 2 diabetes; weight loss is a secondary effect (8–14%) [1][3][7] |
| Prescribing Guidelines | Clinics can prescribe it directly for weight loss without needing diabetes documentation [2][6] | Using it for weight loss is off-label; many clinics advise against it due to supply constraints and ethical concerns [1][5][7] |
| Clinical Trial Results | Demonstrates 15–18% average weight loss over 68 weeks [2][3] | Demonstrates 12–14% average weight loss [2][3] |
| Insurance Coverage | Covered when appropriate documentation for obesity is provided [3] | Typically covered only with documentation for Type 2 diabetes [3] |
Important Considerations:
- Cost: Both medications are expensive without insurance, with out-of-pocket costs ranging from $650 to $1,500 per month [3]. In the UK, Wegovy starts around £89–£119 for lower doses, while Ozempic ranges £130–£250 [1].
- Supply Constraints: Ozempic faces significant global shortages, making it harder for clinics to prescribe for non-diabetic purposes [1][5].
- Medical Supervision: Switching between the two or using either requires clinical supervision [1][9].
Recommendation:
If your primary goal is weight loss, choose Wegovy and seek online clinics that specialize in obesity management (e.g., D'.M., Calibrate, or Ro). These clinics are more likely to approve Wegovy quickly because it aligns with their covered condition. Avoid clinics that prescribe Ozempic for weight loss unless you have a documented diagnosis of type 2 diabetes, as this is not the standard or recommended practice [1][5][7].